Corundum Neuroscience

cnsfund.com

Formerly Joy Ventures

Venture Studio

Tech Verticals Preferences

Neuroscience Biotechnology, Digital Health, Health, Healthtech, Medical Devices, MedTech, Mobile Applications, Pharmaceuticals

General Data

Established	2017
Current Active Portfolio Companies:	9
Reg. Number:	abCDe

DESCRIPTION

Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The Corundum Neuroscience team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and quality of life. Those areas include anxiety, depression, PTSD, chronic pain, sleep and neurodegenerative disorders.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
574FCDA4-78EC-E611-80CF-00155D0B832C		Corundum Open Innovation Ltd. (COIF)
C36BA6B6-3EF1-E611-80CF-00155D0B832C	Investment Arm	Corundum Neuroscience	Corundum Open Innovation Ltd. (COIF)

REMARKS

Date	Remark
01/09/2023	Corundum Neuroscience was previously called Joy Ventures and it focused on building, funding and supporting companies developing consumer products for wellbeing. In September 2023 it has relaunched as Corundum neuroscience and its sharpened focus is now on facilitating greater neuroscience research and innovation.
01/06/2016	Portfolio companies outside of Israel: Embr Labs, Empathic Technologies

CONTACT INFO

Expand / Collapse All

Main Address: Herzliya, Israel

Address	11 Ha Menofim St., Akerstein building B, 3rd Floor
City	Herzliya
Country	Israel
Zip	4672562

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Liron Nunez-Weissman	CEO	Beyond Mobility Garage (CTO)
Dr. Joshua Schulman	Chief Scientist	NeuroKaire (SVP, Partnerships & Innovation)
Dr. Ruthi Aladjem	Chief Product Strategist
Mr. Dori Zimner	Investment Associate
Ms. Sabrina Kestenbaum	Marketing Director	SOSA (Community Manager)
Mr. Itsik Francis	Head of Business Development	OurCrowd (Principal)

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Investment in Fund

Feb. 07, 2017

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Venture Capital Fund	abCDe
abC Defghij	Holding Company	abCDe

Investment Data

Managed Capital	abCDe

Preferences

Type of Financing	Equity
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Digital Health

67%

Consumer-Oriented Software

22%

Biomed

11%

	PORTFOLIO COMPANIES

Current Portfolio Companies (9)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

GMH

GMH is actively marketing Prism for PTSD, an FDA-cleared device being used today to treat patients with PTSD in a growing list of psychiatry clinics across the US. An expert team in the US is leading commercial growth, market access, medical strategy and training programs.
GMH is the first company to develop a PTSD treatment based on a proprietary amygdala-based digital biomarker.  While medical biomarkers measure tissue to assess disease, the EFP (EEG-fMRI-Pattern) biomarker measures brain activity associated with mental health disorders.
This is the world’s first biomarker that harnesses advanced statistical models to register fMRI amygdala data to readily accessible EEG. This innovation brings the power of evidence-based, precision neurofeedback to any psychiatry clinic treating PTSD patients.

Dig. Health

First Round

11/01/2022

N/A

$10m

Mind Guard

Hour25.ai is a real-time focus solution, improving emotional regulation for knowledge workers.

CO SW

Seed

01/11/2020

N/A

Myndlift

Dig. Health

First Round

02/10/2017

N/A

$1m

NYX Technologies

NYX is a neurotechnology company currently developing a wearable headband that monitors and changes brain activity in real time. This technology allows the wearer to improve their sleep during the night and reduce their stress during the day.

Dig. Health

First Round	13/06/2022	N/A	$2.5m
Seed	01/09/2019	N/A	$1.5m

Pheno.AI

Biomed

Seed

01/06/2022

N/A

Reflect Innovation

Dig. Health

First Round	06/05/2024	N/A	$3m
Seed - Extended	02/03/2021	$3m	$3m
Seed	01/06/2018	N/A	$1.1m

Vi Technologies

Vi builds fun, immersive, and affordable fitness experiences. Specifically, they build and power mobile & cloud applications that deliver workout experiences using vast amounts of data in real-time to create personalized and social workout experiences.

Dig. Health

Third Round	01/05/2020	N/A	N/A
Second Round	19/06/2018	N/A	$20m

Wisdo

Dig. Health

First Round - Extended	21/12/2022	N/A	$5m
First Round	13/12/2018	N/A	$6m

Zoog

CO SW

Seed - Extended	01/11/2020	$0.12m	$0.12m
Seed	01/07/2020	N/A	$0.6m

Historic Portfolio (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Sanga

Ceased to Operate

CO SW

Seed

18/07/2018

N/A

Last Updated:	abCDe
IVC Number:	abCDe